Top Drug Discovery and Development Companies In APAC
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Drug Discovery and Development Companies In APAC
Drug Discovery and Development News
Scaling Biopharmaceutical Manufacturing through Integrated CDMO Expertise
Tuesday, April 21, 2026
Biopharmaceutical innovation has expanded rapidly, yet manufacturing capacity and process complexity still shape how quickly therapies reach patients. Executives selecting contract development and manufacturing organizations face a landscape defined by complex biologics, accelerated clinical timelines and tighter regulatory scrutiny across regions. These pressures place manufacturing partners under closer examination, as development success now depends as much on industrial readiness as on scientific discovery. Manufacturing scale remains a persistent challenge. Many emerging biologic therapies move from laboratory validation to clinical demand faster than supporting production
APAC's Growth in Regenerative Medicine
Tuesday, March 10, 2026
Regenerative medicine is a transformative field poised to redefine healthcare by harnessing the body’s natural healing mechanisms to repair, replace, and regenerate damaged tissues and organs. Encompassing diverse approaches such as tissue engineering, cell and gene therapies, and advanced biomaterials, its core aim is to restore normal physiological function lost to congenital conditions, disease, injury, or aging. Central to its innovation are technologies like pluripotent stem cells, extracellular matrix scaffolds, and gene-editing tools such as CRISPR, which enable the development of more effective and personalized therapies. The Asia-Pacific (APAC) region, with its demographics
The Growing Ecosystem of Single-Cell Sequencing Services in Asia-Pacific
Monday, April 07, 2025
Single-cell sequencing (SCS) has fundamentally reshaped biological research, shifting from bulk tissue analysis to high-resolution interrogation of individual cellular states. As of early 2025, the APAC SCS service market is characterized by increasing accessibility, technological sophistication, diverse applications, and significant regional investment, positioning it as a crucial hub for life sciences innovation. The APAC single-cell sequencing service market is escalating government and private investment in biomedical research, precision medicine initiatives, and biotechnology across numerous APAC nations, creating substantial demand. Governments recognize the po
Japan's Rise as a Leader in Clinical Diagnostics and Trials
Friday, March 21, 2025
Japan’s clinical testing sector is poised for significant advancements in 2025, driven by rapid expansion, innovative diagnostic methodologies, and enhanced regulatory frameworks. Integrating cutting-edge technologies and centralized infrastructure fosters a future characterized by high-precision diagnostics and optimized clinical trial management, ultimately improving healthcare outcomes. This evolution is underpinned by key developments, including automated laboratory processes and streamlined regulatory approvals, positioning Japan as a rising global leader in clinical testing and diagnostic innovation. Market Expansion & Infrastructure Development
